$VVOS
Vivos Therapeutics Inc
PRICE
$1.285 ▲5.328%
Last Close
VOLUME
30,719
DAY RANGE
1.16 - 1.28
52 WEEK
1.11 - 7.09
Join Discuss about VVOS with like-minded investors
@Baljit123 #StockTraders.NET
BBIG - Ideally 4.50 / 4.75 / 5.00 to short in the morning VVOS - Looking for 2.30 / 2.50 lines to short SBEV - Looking for 4.00 / 4.20 / 4.50 to scale in short DWAC - Very beaten down. Looking for 82 / 84 / 86 to scale in short. WIDE RANGE so use less size DATS - Not up enough yet so will wait for this to get tons of attention first IMTE - A lot are stalking it for a First Red Day setup, but I am not in love with it because it feels like it can trap. Rather have it tank and short bounces after
147 Replies 9 👍 6 🔥
@Baljit123 #StockTraders.NET
BBIG LHF - frd yesterday, so 4.5 - 5 area for me, over 5 i dont like it anymore VVOS LHF - 2.3 - 2.6 stop over prev hod, if strong and hold over 2.6 likely im gonna get out GMVD LHF - 5.7 - 6.3 stop over i dont think it will get to 6.3 tho BKKT LHF - doubt it will pop but if any 5.5 - 6 SBEV LHF - 4 - 4.5 area for me stop over 4.6 if holds
84 Replies 12 👍 13 🔥
@soheil.n #StockTraders.NET
if 2.35s reclaim may go for nhod...as in type 4 play > @maletone said: $vvos close
93 Replies 14 👍 8 🔥
Key Metrics
Market Cap
28.07 M
Beta
1.47
Avg. Volume
47.75 K
Shares Outstanding
23.01 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-11
Next Dividend Date
Company Information
Vivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including obstructive sleep apnea (OSA). Vivos believes that its Vivos System technology represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution for people with mild-to-moderate OSA. Combining technologies and protocols that alter the size, shape and position of the tissues of the upper human airway, the Vivos System opens airway space and can eliminate or significantly reduce symptoms and conditions associated with mild-to-moderate OSA. The Vivos System has been shown to significantly lower Apnea Hypopnea Index scores and improve other conditions associated with OSA. Sales of the Vivos System are driven by the Vivos Integrated Practice (VIP) program, which offers dentists training and value-added services in connection with their use of the Vivos System.
Website: www.vivoslife.com
HQ: ,
Related News